nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—DDC—blood plasma—systemic lupus erythematosus	0.0361	0.0805	CbGeAlD
Droxidopa—PAH—kidney—systemic lupus erythematosus	0.0287	0.064	CbGeAlD
Droxidopa—ADRB3—connective tissue—systemic lupus erythematosus	0.0263	0.0587	CbGeAlD
Droxidopa—PAH—nervous system—systemic lupus erythematosus	0.0188	0.042	CbGeAlD
Droxidopa—DDC—nephron tubule—systemic lupus erythematosus	0.0186	0.0415	CbGeAlD
Droxidopa—PAH—central nervous system—systemic lupus erythematosus	0.0181	0.0404	CbGeAlD
Droxidopa—DDC—kidney—systemic lupus erythematosus	0.0163	0.0365	CbGeAlD
Droxidopa—DDC—cortex of kidney—systemic lupus erythematosus	0.0159	0.0356	CbGeAlD
Droxidopa—ADRA1B—kidney—systemic lupus erythematosus	0.0129	0.0288	CbGeAlD
Droxidopa—SLC16A10—nephron tubule—systemic lupus erythematosus	0.0128	0.0285	CbGeAlD
Droxidopa—ADRA2A—blood plasma—systemic lupus erythematosus	0.0121	0.0271	CbGeAlD
Droxidopa—DDC—lung—systemic lupus erythematosus	0.0116	0.0259	CbGeAlD
Droxidopa—SLC16A10—cortex of kidney—systemic lupus erythematosus	0.0109	0.0244	CbGeAlD
Droxidopa—ADRB1—connective tissue—systemic lupus erythematosus	0.0108	0.024	CbGeAlD
Droxidopa—DDC—nervous system—systemic lupus erythematosus	0.0107	0.024	CbGeAlD
Droxidopa—DDC—central nervous system—systemic lupus erythematosus	0.0103	0.0231	CbGeAlD
Droxidopa—Blood pressure increased—Leflunomide—systemic lupus erythematosus	0.0101	0.0354	CcSEcCtD
Droxidopa—SLC16A10—lymphoid tissue—systemic lupus erythematosus	0.00963	0.0215	CbGeAlD
Droxidopa—Mesalazine—PPARG—systemic lupus erythematosus	0.00936	0.405	CrCbGaD
Droxidopa—SLC16A10—tendon—systemic lupus erythematosus	0.00905	0.0202	CbGeAlD
Droxidopa—ADRA1B—nervous system—systemic lupus erythematosus	0.00845	0.0189	CbGeAlD
Droxidopa—ADRA1D—nervous system—systemic lupus erythematosus	0.00827	0.0185	CbGeAlD
Droxidopa—ADRA1B—central nervous system—systemic lupus erythematosus	0.00814	0.0182	CbGeAlD
Droxidopa—ADRA1D—central nervous system—systemic lupus erythematosus	0.00796	0.0178	CbGeAlD
Droxidopa—SLC16A10—lung—systemic lupus erythematosus	0.00794	0.0177	CbGeAlD
Droxidopa—ADRA2C—nephron tubule—systemic lupus erythematosus	0.00785	0.0175	CbGeAlD
Droxidopa—ADRA2C—kidney—systemic lupus erythematosus	0.0069	0.0154	CbGeAlD
Droxidopa—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00672	0.015	CbGeAlD
Droxidopa—ADRB1—lung—systemic lupus erythematosus	0.00649	0.0145	CbGeAlD
Droxidopa—ADRA2A—connective tissue—systemic lupus erythematosus	0.00647	0.0144	CbGeAlD
Droxidopa—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.00622	0.0139	CbGeAlD
Droxidopa—Cardiac failure congestive—Mycophenolate mofetil—systemic lupus erythematosus	0.00609	0.0214	CcSEcCtD
Droxidopa—ADRB1—nervous system—systemic lupus erythematosus	0.00601	0.0134	CbGeAlD
Droxidopa—ADRB1—central nervous system—systemic lupus erythematosus	0.00578	0.0129	CbGeAlD
Droxidopa—Cardiac failure congestive—Prednisolone—systemic lupus erythematosus	0.00568	0.0199	CcSEcCtD
Droxidopa—ADRA2C—tendon—systemic lupus erythematosus	0.00557	0.0124	CbGeAlD
Droxidopa—Cardiac failure congestive—Hydrocortisone—systemic lupus erythematosus	0.00555	0.0195	CcSEcCtD
Droxidopa—SLC6A2—lung—systemic lupus erythematosus	0.00552	0.0123	CbGeAlD
Droxidopa—Urinary tract infection—Leflunomide—systemic lupus erythematosus	0.00549	0.0193	CcSEcCtD
Droxidopa—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.00536	0.012	CbGeAlD
Droxidopa—Cardiac failure congestive—Triamcinolone—systemic lupus erythematosus	0.00522	0.0183	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—systemic lupus erythematosus	0.00521	0.0183	CcSEcCtD
Droxidopa—SLC6A2—nervous system—systemic lupus erythematosus	0.00511	0.0114	CbGeAlD
Droxidopa—Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.00504	0.218	CrCbGaD
Droxidopa—SLC6A2—central nervous system—systemic lupus erythematosus	0.00492	0.011	CbGeAlD
Droxidopa—ADRA2C—lung—systemic lupus erythematosus	0.00489	0.0109	CbGeAlD
Droxidopa—Arrhythmia—Azathioprine—systemic lupus erythematosus	0.0048	0.0168	CcSEcCtD
Droxidopa—Epinephrine—TNF—systemic lupus erythematosus	0.00479	0.207	CrCbGaD
Droxidopa—ADRA1A—nervous system—systemic lupus erythematosus	0.00475	0.0106	CbGeAlD
Droxidopa—Cardiac failure congestive—Dexamethasone—systemic lupus erythematosus	0.00474	0.0166	CcSEcCtD
Droxidopa—Cardiac failure congestive—Betamethasone—systemic lupus erythematosus	0.00474	0.0166	CcSEcCtD
Droxidopa—ADRA1A—central nervous system—systemic lupus erythematosus	0.00457	0.0102	CbGeAlD
Droxidopa—Arrhythmia—Leflunomide—systemic lupus erythematosus	0.00453	0.0159	CcSEcCtD
Droxidopa—ADRA2C—nervous system—systemic lupus erythematosus	0.00453	0.0101	CbGeAlD
Droxidopa—ADRA2A—tendon—systemic lupus erythematosus	0.00444	0.00993	CbGeAlD
Droxidopa—ADRA2C—central nervous system—systemic lupus erythematosus	0.00436	0.00973	CbGeAlD
Droxidopa—Urinary tract infection—Cyclosporine—systemic lupus erythematosus	0.00424	0.0149	CcSEcCtD
Droxidopa—Headache—Dapsone—systemic lupus erythematosus	0.00423	0.0148	CcSEcCtD
Droxidopa—Urinary tract infection—Mycophenolate mofetil—systemic lupus erythematosus	0.00414	0.0145	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—systemic lupus erythematosus	0.00413	0.0145	CcSEcCtD
Droxidopa—Nausea—Dapsone—systemic lupus erythematosus	0.00401	0.0141	CcSEcCtD
Droxidopa—Mesalazine—PTGS2—systemic lupus erythematosus	0.00395	0.171	CrCbGaD
Droxidopa—ADRA2A—lung—systemic lupus erythematosus	0.0039	0.00871	CbGeAlD
Droxidopa—Hypertension—Leflunomide—systemic lupus erythematosus	0.00381	0.0134	CcSEcCtD
Droxidopa—ADRA2A—nervous system—systemic lupus erythematosus	0.00361	0.00807	CbGeAlD
Droxidopa—Arrhythmia—Cyclosporine—systemic lupus erythematosus	0.0035	0.0123	CcSEcCtD
Droxidopa—ADRA2A—central nervous system—systemic lupus erythematosus	0.00348	0.00777	CbGeAlD
Droxidopa—Arrhythmia—Mycophenolate mofetil—systemic lupus erythematosus	0.00341	0.012	CcSEcCtD
Droxidopa—Arrhythmia—Prednisolone—systemic lupus erythematosus	0.00318	0.0112	CcSEcCtD
Droxidopa—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.00315	0.011	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—systemic lupus erythematosus	0.00311	0.0109	CcSEcCtD
Droxidopa—Syncope—Mycophenolate mofetil—systemic lupus erythematosus	0.00298	0.0105	CcSEcCtD
Droxidopa—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.00297	0.0104	CcSEcCtD
Droxidopa—Hypertension—Cyclosporine—systemic lupus erythematosus	0.00294	0.0103	CcSEcCtD
Droxidopa—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.00293	0.0103	CcSEcCtD
Droxidopa—Loss of consciousness—Mycophenolate mofetil—systemic lupus erythematosus	0.00292	0.0102	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.00292	0.0102	CcSEcCtD
Droxidopa—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.00287	0.0101	CcSEcCtD
Droxidopa—Confusional state—Cyclosporine—systemic lupus erythematosus	0.00281	0.00984	CcSEcCtD
Droxidopa—Syncope—Prednisolone—systemic lupus erythematosus	0.00278	0.00976	CcSEcCtD
Droxidopa—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.00274	0.0096	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisolone—systemic lupus erythematosus	0.00273	0.00956	CcSEcCtD
Droxidopa—Syncope—Hydrocortisone—systemic lupus erythematosus	0.00272	0.00953	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—systemic lupus erythematosus	0.00268	0.00939	CcSEcCtD
Droxidopa—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.00267	0.00936	CcSEcCtD
Droxidopa—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	0.00266	0.00934	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.00266	0.00932	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.00266	0.00932	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.00262	0.00917	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—systemic lupus erythematosus	0.00256	0.00897	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—systemic lupus erythematosus	0.00255	0.00895	CcSEcCtD
Droxidopa—Dizziness—Azathioprine—systemic lupus erythematosus	0.00252	0.00885	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	0.00251	0.00879	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	0.0025	0.00877	CcSEcCtD
Droxidopa—Shock—Prednisolone—systemic lupus erythematosus	0.00249	0.00873	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—systemic lupus erythematosus	0.00246	0.00864	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.00246	0.00862	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—systemic lupus erythematosus	0.00243	0.00853	CcSEcCtD
Droxidopa—Headache—Azathioprine—systemic lupus erythematosus	0.00239	0.00839	CcSEcCtD
Droxidopa—Dizziness—Leflunomide—systemic lupus erythematosus	0.00238	0.00836	CcSEcCtD
Droxidopa—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.00234	0.00821	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—systemic lupus erythematosus	0.00232	0.00814	CcSEcCtD
Droxidopa—Syncope—Betamethasone—systemic lupus erythematosus	0.00232	0.00814	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—systemic lupus erythematosus	0.00231	0.00811	CcSEcCtD
Droxidopa—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.00229	0.00804	CcSEcCtD
Droxidopa—Shock—Triamcinolone—systemic lupus erythematosus	0.00229	0.00803	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—systemic lupus erythematosus	0.00229	0.00801	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.00228	0.00798	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.00228	0.00798	CcSEcCtD
Droxidopa—Nausea—Azathioprine—systemic lupus erythematosus	0.00227	0.00795	CcSEcCtD
Droxidopa—Headache—Leflunomide—systemic lupus erythematosus	0.00226	0.00792	CcSEcCtD
Droxidopa—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00224	0.00784	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—systemic lupus erythematosus	0.00223	0.00784	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00223	0.00784	CcSEcCtD
Droxidopa—Nausea—Leflunomide—systemic lupus erythematosus	0.00214	0.00751	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00209	0.00732	CcSEcCtD
Droxidopa—Shock—Dexamethasone—systemic lupus erythematosus	0.00208	0.00729	CcSEcCtD
Droxidopa—Shock—Betamethasone—systemic lupus erythematosus	0.00208	0.00729	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00204	0.00715	CcSEcCtD
Droxidopa—Syncope—Prednisone—systemic lupus erythematosus	0.00202	0.00709	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.00198	0.00695	CcSEcCtD
Droxidopa—Hypertension—Prednisone—systemic lupus erythematosus	0.00195	0.00682	CcSEcCtD
Droxidopa—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00192	0.00673	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00191	0.00671	CcSEcCtD
Droxidopa—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00184	0.00645	CcSEcCtD
Droxidopa—Shock—Prednisone—systemic lupus erythematosus	0.00181	0.00635	CcSEcCtD
Droxidopa—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00179	0.00629	CcSEcCtD
Droxidopa—Headache—Cyclosporine—systemic lupus erythematosus	0.00174	0.00611	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.00174	0.0061	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.00174	0.0061	CcSEcCtD
Droxidopa—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.0017	0.00596	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—systemic lupus erythematosus	0.00167	0.00587	CcSEcCtD
Droxidopa—Nausea—Cyclosporine—systemic lupus erythematosus	0.00165	0.0058	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00164	0.00573	CcSEcCtD
Droxidopa—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00161	0.00565	CcSEcCtD
Droxidopa—Headache—Prednisolone—systemic lupus erythematosus	0.00159	0.00556	CcSEcCtD
Droxidopa—Confusional state—Methotrexate—systemic lupus erythematosus	0.00155	0.00544	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—systemic lupus erythematosus	0.00155	0.00543	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00154	0.0054	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00154	0.00539	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.00152	0.00532	CcSEcCtD
Droxidopa—Nausea—Prednisolone—systemic lupus erythematosus	0.0015	0.00527	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00147	0.00515	CcSEcCtD
Droxidopa—Headache—Triamcinolone—systemic lupus erythematosus	0.00146	0.00511	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—systemic lupus erythematosus	0.00146	0.0051	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—systemic lupus erythematosus	0.0014	0.0049	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—systemic lupus erythematosus	0.0014	0.0049	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—systemic lupus erythematosus	0.00138	0.00485	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00138	0.00484	CcSEcCtD
Droxidopa—Headache—Dexamethasone—systemic lupus erythematosus	0.00132	0.00464	CcSEcCtD
Droxidopa—Headache—Betamethasone—systemic lupus erythematosus	0.00132	0.00464	CcSEcCtD
Droxidopa—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.00127	0.00444	CcSEcCtD
Droxidopa—Nausea—Betamethasone—systemic lupus erythematosus	0.00125	0.0044	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—systemic lupus erythematosus	0.00125	0.0044	CcSEcCtD
Droxidopa—Dizziness—Prednisone—systemic lupus erythematosus	0.00122	0.00427	CcSEcCtD
Droxidopa—Headache—Prednisone—systemic lupus erythematosus	0.00115	0.00404	CcSEcCtD
Droxidopa—Nausea—Prednisone—systemic lupus erythematosus	0.00109	0.00383	CcSEcCtD
Droxidopa—Dizziness—Methotrexate—systemic lupus erythematosus	0.00102	0.00357	CcSEcCtD
Droxidopa—Headache—Methotrexate—systemic lupus erythematosus	0.000963	0.00338	CcSEcCtD
Droxidopa—Nausea—Methotrexate—systemic lupus erythematosus	0.000913	0.0032	CcSEcCtD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.29e-05	0.000381	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—JUNB—systemic lupus erythematosus	9.28e-05	0.000381	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—RXRA—systemic lupus erythematosus	9.21e-05	0.000377	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CD80—systemic lupus erythematosus	9.18e-05	0.000376	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.15e-05	0.000375	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	9.09e-05	0.000373	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.08e-05	0.000372	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	9.08e-05	0.000372	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LYN—systemic lupus erythematosus	9.03e-05	0.00037	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.02e-05	0.00037	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.95e-05	0.000367	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.95e-05	0.000367	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.94e-05	0.000366	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—F2—systemic lupus erythematosus	8.91e-05	0.000365	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	8.9e-05	0.000365	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—VEGFA—systemic lupus erythematosus	8.88e-05	0.000364	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—C3—systemic lupus erythematosus	8.87e-05	0.000364	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	8.86e-05	0.000363	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.82e-05	0.000362	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.81e-05	0.000361	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—JUNB—systemic lupus erythematosus	8.79e-05	0.00036	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—F2—systemic lupus erythematosus	8.77e-05	0.000359	CbGpPWpGaD
Droxidopa—DDC—Metabolism—EP300—systemic lupus erythematosus	8.75e-05	0.000359	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PRL—systemic lupus erythematosus	8.75e-05	0.000358	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—systemic lupus erythematosus	8.73e-05	0.000358	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PRL—systemic lupus erythematosus	8.67e-05	0.000355	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—JUNB—systemic lupus erythematosus	8.65e-05	0.000354	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.58e-05	0.000352	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—F2—systemic lupus erythematosus	8.58e-05	0.000352	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PRL—systemic lupus erythematosus	8.55e-05	0.000351	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TYK2—systemic lupus erythematosus	8.55e-05	0.00035	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL2—systemic lupus erythematosus	8.54e-05	0.00035	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.5e-05	0.000348	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2—systemic lupus erythematosus	8.49e-05	0.000348	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.43e-05	0.000346	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.39e-05	0.000344	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.35e-05	0.000342	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.31e-05	0.000341	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—C3—systemic lupus erythematosus	8.24e-05	0.000338	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.22e-05	0.000337	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—systemic lupus erythematosus	8.15e-05	0.000334	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PRL—systemic lupus erythematosus	8.09e-05	0.000332	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	7.97e-05	0.000327	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PRL—systemic lupus erythematosus	7.97e-05	0.000326	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.94e-05	0.000325	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.83e-05	0.000321	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.82e-05	0.000321	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.81e-05	0.00032	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.79e-05	0.000319	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—F2—systemic lupus erythematosus	7.79e-05	0.000319	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TYK2—systemic lupus erythematosus	7.75e-05	0.000318	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.72e-05	0.000316	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—JUNB—systemic lupus erythematosus	7.68e-05	0.000315	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—JAK1—systemic lupus erythematosus	7.68e-05	0.000315	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.62e-05	0.000312	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—EP300—systemic lupus erythematosus	7.62e-05	0.000312	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NOS3—systemic lupus erythematosus	7.61e-05	0.000312	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—RXRA—systemic lupus erythematosus	7.48e-05	0.000307	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.3e-05	0.000299	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR5—systemic lupus erythematosus	7.27e-05	0.000298	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.27e-05	0.000298	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—F2—systemic lupus erythematosus	7.24e-05	0.000297	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—VEGFA—systemic lupus erythematosus	7.22e-05	0.000296	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.21e-05	0.000296	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.17e-05	0.000294	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.14e-05	0.000293	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	7.14e-05	0.000292	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2—systemic lupus erythematosus	7.11e-05	0.000292	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—C3—systemic lupus erythematosus	7.11e-05	0.000291	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.1e-05	0.000291	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRL—systemic lupus erythematosus	7.08e-05	0.00029	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.07e-05	0.00029	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—JAK1—systemic lupus erythematosus	6.99e-05	0.000287	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.98e-05	0.000286	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.94e-05	0.000285	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—JAK1—systemic lupus erythematosus	6.93e-05	0.000284	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	6.84e-05	0.00028	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.78e-05	0.000278	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR5—systemic lupus erythematosus	6.63e-05	0.000272	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	6.62e-05	0.000271	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.61e-05	0.000271	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.59e-05	0.00027	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	6.57e-05	0.000269	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR5—systemic lupus erythematosus	6.57e-05	0.000269	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.53e-05	0.000268	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.5e-05	0.000267	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	6.48e-05	0.000266	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—systemic lupus erythematosus	6.48e-05	0.000266	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—C3—systemic lupus erythematosus	6.48e-05	0.000265	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—JAK1—systemic lupus erythematosus	6.47e-05	0.000265	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.47e-05	0.000265	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—systemic lupus erythematosus	6.45e-05	0.000264	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.45e-05	0.000264	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—systemic lupus erythematosus	6.42e-05	0.000263	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—systemic lupus erythematosus	6.42e-05	0.000263	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—C3—systemic lupus erythematosus	6.42e-05	0.000263	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.39e-05	0.000262	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—JAK1—systemic lupus erythematosus	6.37e-05	0.000261	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	6.34e-05	0.00026	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—C3—systemic lupus erythematosus	6.34e-05	0.00026	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.3e-05	0.000258	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—F2—systemic lupus erythematosus	6.24e-05	0.000256	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR5—systemic lupus erythematosus	6.13e-05	0.000251	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—systemic lupus erythematosus	6.11e-05	0.00025	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.08e-05	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.05e-05	0.000248	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR5—systemic lupus erythematosus	6.04e-05	0.000247	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—systemic lupus erythematosus	6e-05	0.000246	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—C3—systemic lupus erythematosus	5.99e-05	0.000246	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CD80—systemic lupus erythematosus	5.98e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.95e-05	0.000244	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—systemic lupus erythematosus	5.9e-05	0.000242	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—C3—systemic lupus erythematosus	5.9e-05	0.000242	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.86e-05	0.00024	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARG—systemic lupus erythematosus	5.81e-05	0.000238	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EP300—systemic lupus erythematosus	5.79e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.78e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	5.69e-05	0.000233	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	5.66e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	5.63e-05	0.000231	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—F2—systemic lupus erythematosus	5.56e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—systemic lupus erythematosus	5.56e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.48e-05	0.000225	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	5.45e-05	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	5.4e-05	0.000221	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.37e-05	0.00022	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	5.36e-05	0.00022	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CD80—systemic lupus erythematosus	5.33e-05	0.000219	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.28e-05	0.000217	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—F2—systemic lupus erythematosus	5.26e-05	0.000216	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	5.26e-05	0.000216	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	5.24e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	5.24e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—systemic lupus erythematosus	5.23e-05	0.000214	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	5.18e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.07e-05	0.000208	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TYK2—systemic lupus erythematosus	5.05e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CD80—systemic lupus erythematosus	5.05e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.03e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	5.02e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NOS3—systemic lupus erythematosus	5e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.98e-05	0.000204	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	4.97e-05	0.000204	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.96e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	4.96e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.91e-05	0.000201	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.87e-05	0.0002	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	4.87e-05	0.0002	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	4.72e-05	0.000194	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	4.69e-05	0.000192	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.62e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.6e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	4.6e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	4.57e-05	0.000187	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.56e-05	0.000187	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.52e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.5e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.48e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.42e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	4.41e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.29e-05	0.000176	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	4.27e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	4.26e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	4.25e-05	0.000174	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	4.2e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.19e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	4.18e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	4.18e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.11e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.1e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	4.1e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	4.06e-05	0.000166	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	3.98e-05	0.000163	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.96e-05	0.000162	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.91e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.88e-05	0.000159	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	3.83e-05	0.000157	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.83e-05	0.000157	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.81e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.81e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	3.8e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	3.79e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—systemic lupus erythematosus	3.79e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.78e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	3.77e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—systemic lupus erythematosus	3.75e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.73e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.72e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	3.71e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.65e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.62e-05	0.000149	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.62e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.61e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.59e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.58e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.57e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.56e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.55e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	3.54e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.53e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	3.53e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	3.49e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.47e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.46e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	3.44e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	3.4e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.4e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EP300—systemic lupus erythematosus	3.36e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	3.35e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.34e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.3e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.29e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.28e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.25e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.22e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.18e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	3.18e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.17e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	3.13e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	3.1e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	3.09e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.08e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.01e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.99e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.96e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.96e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.94e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.93e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.92e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.92e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.88e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.86e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	2.78e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.76e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.72e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.72e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.71e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.63e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.58e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	2.47e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.45e-05	0.0001	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.42e-05	9.91e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	2.25e-05	9.22e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.25e-05	9.2e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.23e-05	9.14e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—systemic lupus erythematosus	2.2e-05	9.02e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.08e-05	8.54e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.05e-05	8.4e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.82e-05	7.46e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.69e-05	6.94e-05	CbGpPWpGaD
